You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resectable colon cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Early Breast Cancer Trial in Worldwide (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Early Breast Cancer
  • Rockville, Maryland
  • +106 more
Jan 19, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Completed
  • Fallopian Tube Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Single Patient Classifier Prediction for Stage II and III

    Recruiting
    • Gastric Cancer
      • Seoul, Korea, Republic of
        Novomics. Co., Ltd.
      Jul 21, 2022

      Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)

      Recruiting
      • Platinum-resistant Epithelial Ovarian Cancer
      • Maveropepimut-S
      • Cyclophosphamide 50mg
      • Ocala, Florida
      • +1 more
      Jul 20, 2022

      HER2 Negative Breast Cancer Trial in Zhenzhou (Eribulin plus Tucidinostat)

      Not yet recruiting
      • HER2 Negative Breast Cancer
      • Eribulin plus Tucidinostat
      • Zhenzhou, China
        Henan Cancer Hospital
      May 26, 2022

      Lung Diseases Trial in Boston (lung resection with Lung Resection Marker Locator Kit)

      Recruiting
      • Lung Diseases
      • lung resection with Lung Resection Marker Locator Kit
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Apr 6, 2022

      Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in Scottsdale, Jacksonville, Rochester (procedure, other,

      Recruiting
      • Malignant Solid Neoplasm
      • Metastatic Malignant Neoplasm in the Brain
      • Conventional Surgery
      • +3 more
      • Scottsdale, Arizona
      • +2 more
      Feb 2, 2022

      Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)

      Terminated
      • Metastatic Colorectal Cancer (CRC)
      • Shanghai, China
        Shanghai East Hospital, Tongji University China
      Apr 19, 2022

      TNBC - Triple-Negative Breast Cancer Trial in Beijing (Eribulin, anti-PD-1 antibody)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Beijing, Beijing, China
        The Fifth Medical Center of PLA General Hospital
      May 29, 2022

      Colorectal Cancer Trial in Kent Ridge (Current practice, Targeted intervention programme)

      Recruiting
      • Colorectal Cancer
      • Current practice
      • Targeted intervention programme
      • Kent Ridge, Singapore
        National University Hospital
      Apr 19, 2022

      NSCLC Trial in Worldwide (DS-1062a)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Phoenix, Arizona
      • +82 more
      Jul 27, 2022

      Database to prospectivelY aSSEss Changing TherapY Landscape in

      Recruiting
      • Metastatic Renal Cell Carcinoma
        • Iowa City, Iowa
        • +7 more
        Oct 13, 2022

        Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

        Completed
        • Serous Ovarian Carcinoma
        • Low Grade Serous Ovarian Carcinoma
        • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
        • Lyon, France
          Hospices civils de Lyon
        Feb 14, 2023

        Dyspepsia, Peptic Ulcer Disease, Gastroesophageal Reflux Trial in Sha Tin (MCCE)

        Active, not recruiting
        • Dyspepsia
        • +4 more
        • MCCE
        • Sha Tin, New Territories, Hong Kong
          Prince of Wales Hospital, The Chinese University of Hong Kong
        Nov 28, 2022

        Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

        Recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • +2 more
        • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 13, 2022

        High-grade Cervical Intraepithelial Neoplasia Trial in Stockholm (HPV testing)

        Active, not recruiting
        • High-grade Cervical Intraepithelial Neoplasia
        • HPV testing
        • Stockholm, Sweden
          Karolinska University Hospital
        Jan 27, 2022

        Host Immune Response to Novel RNA COVID-19 Vaccination

        Recruiting
        • COVID-19 Vaccine
        • Cancer
        • COVID-19 Vaccine
        • San Antonio, Texas
          Mays Cancer Center, UT Health San Antonio
        Apr 22, 2022

        Breast Carcinoma Trial in Philadelphia (Ultrasonsgraphy, Perflutren Lipid Microcpheres, Contrast - Enhanced Ultrasound)

        Recruiting
        • Breast Carcinoma
        • Ultrasonsgraphy
        • +2 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University Hospital
        Aug 1, 2022

        Myeloma Novel Drug Discovery Ver 1.2

        Recruiting
        • Multiple Myeloma
        • Observational study - sample collection only.
        • London Borough of Sutton, United Kingdom
          The Royal Marsden NHS Foundation Trust
        Aug 1, 2023

        MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

        Not yet recruiting
        • MTAP-null Non-Small-Cell Lung Cancer
        • MTAP-null Solid Tumors
        • (no location specified)
        Jul 27, 2023

        Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)

        Terminated
        • Adenocarcinoma of the Prostate
        • Muscadine Plus
        • Placebos
        • Duarte, California
        • +12 more
        Dec 6, 2022

        Breast Cancer, Fatigue Trial in Caen (QISENG, PLACEBO)

        Not yet recruiting
        • Breast Cancer
        • Fatigue
        • QISENG
        • PLACEBO
        • Caen, France
          Centre François Baclesse
        Feb 11, 2022